Skip to main content
. 2022 Sep 30;24(3):404–416. doi: 10.5853/jos.2022.01606

Table 3.

Multivariable prognostic factors of poor outcome at 90-day follow-up and mortality

Factor Poor outcome
Mortality
OR 95% CI P OR 95% CI P
Active cancer 11.20 4.62–27.14 <0.001 12.17 5.45–27.16 <0.001
Age 1.02 1.00–1.04 0.039 1.02 1.00–1.04 0.083
Birth control 1.17 0.52–2.65 0.700 0.32 0.07–1.47 0.143
Black race 2.17 1.10–4.27 0.025 2.62 1.20–5.69 0.015
Creatinine 1.97 0.72–5.33 0.185 1.40 0.68–2.86 0.361
Encephalopathy or coma 2.71 1.39–5.30 0.004 1.72 0.79–3.76 0.170
Hemoglobin 0.86 0.77–0.97 0.014 0.97 0.85–1.10 0.618
1+ Hypercoagulable factor 0.88 0.46–1.69 0.694 0.93 0.40–2.14 0.857
Cerebral edema on imaging 0.89 0.46–1.72 0.726 0.90 0.41–1.96 0.789
Hemorrhage on imaging 1.62 0.85–3.09 0.145 1.73 0.79–3.78 0.171
NIHSS 1.07 1.02–1.11 0.002 1.02 0.98–1.07 0.338
Prior VTE 1.64 0.71–3.77 0.246 0.91 0.35–2.36 0.845
Substance use 2.34 1.16–4.71 0.017 2.17 1.03–4.60 0.042

OR, odds ratio; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; VTE, venous thromboembolism.